J3398 HCPCS code: Injection, voretigene neparvovec-rzyl, 1 billion vector genomes
J3398 is the HCPCS Level II code for injection, voretigene neparvovec-rzyl, 1 billion vector genomes. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 150 per day on outpatient hospital claims.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2019-01-01 |
| Last action effective | 2019-01-01 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 150 | CMS Policy |
| practitioner claims | 150 | CMS Policy |
Medicare policy articles for this code
- A56419: Billing and Coding: Voretigene Neparvovec-rzyl (Luxturna®) (Palmetto GBA (MAC - Part A, MAC - Part B))
Covered diagnoses (2 ICD-10-CM codes)
The diagnoses most often listed as covered in the policy articles above:
| ICD-10-CM | Diagnosis | Articles listing it |
|---|---|---|
| H35.50 | Unspecified hereditary retinal dystrophy | 1 |
| H35.52 | Pigmentary retinal dystrophy | 1 |
What changed for J3398
- 2019-01-01: J3398 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3398?
J3398 is the HCPCS Level II code for injection, voretigene neparvovec-rzyl, 1 billion vector genomes. Short descriptor: "Inj luxturna 1 billion vec g".
Does Medicare cover J3398?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
Which diagnoses support coverage for J3398?
Medicare policy articles that cite J3398 list 2 covered ICD-10-CM diagnosis codes across 1 article. The most cited include H35.50 (Unspecified hereditary retinal dystrophy), H35.52 (Pigmentary retinal dystrophy). A listed diagnosis is necessary but not sufficient; the policy's other criteria still apply.
How many units of J3398 can be billed per day?
150 on outpatient hospital claims; 150 on practitioner claims (NCCI medically unlikely edits).
Related J33 codes
- J3300 — Injection, triamcinolone acetonide (triesence), preservative free, 1 mg
- J3301 — Injection, triamcinolone acetonide, not otherwise specified, 10 mg
- J3302 — Injection, triamcinolone diacetate, per 5 mg
- J3303 — Injection, triamcinolone hexacetonide, per 5 mg
- J3304 — Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg
- J3305 — Injection, trimetrexate glucuronate, per 25 mg
- J3310 — Injection, perphenazine, up to 5 mg
- J3315 — Injection, triptorelin pamoate, 3.75 mg
- J3316 — Injection, triptorelin, extended-release, 3.75 mg
- J3320 — Injection, spectinomycin dihydrochloride, up to 2 gm
- J3350 — Injection, urea, up to 40 gm
- J3355 — Injection, urofollitropin, 75 iu
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3398
- Watch J3398 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3398
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.